Expert Interviews

W. Benjamin Nowell, PhD: ArthritisPower Mobile App Identifies MTX-Related Side Effects

January 14, 2022

W. Benjamin Nowell, PhD, in partnership with CreakyJoints, discusses his study, "Patient-Reported Nausea and Fatigue Related to Methotrexate: A Prospective, Self-Controlled Study in the ArthritisPower® Registry.”

James Woody, MD, PhD: Repurposing Adalimumab for Treating Dupuytren's Disease

December 09, 2021

James Woody, MD, PhD, explains the key findings of the Phase 2b clinical trial, “Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD).”

Roy Fleischmann, MD: Efficacy of Olokizumab for Rheumatoid Arthritis Treatment

December 08, 2021

Roy Fleischmann, MD, explores the successful results of the novel IL-6 inhibitor, olokizumab, from 2 randomized clinical trials of the phase 3 global research program CREDO.

Stuart Kassan, MD: Encouraging Self-Advocacy in Newly Diagnosed Patients

December 01, 2021

Stuart Kassan, MD, discusses Rheumatology Research Foundation's recent patient webinar, "Just Diagnosed: Now What?”

Louis Bessette, MD, MSc: Pain Improvement and Patient-Reported Outcomes in Patients with Psoriatic Arthritis

November 30, 2021

Louis Bessette, MD, MSc, explains the impact of early pain improvement on patient-reported outcomes in patients with psoriatic arthritis.

Benjamin Terrier, MD, PhD: Rituximab for Eosinophilic Granulomatosis with Polyangiitis

November 30, 2021

Benjamin Terrier, MD, PhD, discusses his study and ACR presentation, “Rituximab versus Conventional Therapeutic Strategy for Remission Induction in Eosinophilic Granulomatosis with Polyangiitis: A Double-blind, Randomized, Controlled Trial.”

Paul R. Fortin, MD, MPH, FRCPC: COVID-19 Vaccine for Patients With Rheumatic Disease

November 29, 2021

Paul R. Fortin, MD, MPH, FRCPC, discusses the impact of the COVID-19 vaccine in immunosuppressed adults and those with autoimmune diseases.

Courtney Wells, PhD, MPH, MSW: Impact of COVID-19 on the Quality of Life of Patients with Rheumatic Disease

November 22, 2021

Courtney Wells, PhD, MPH, MSW, discusses the impact of the pandemic on the quality of life of patients with rheumatic conditions, with an emphasis on perceived risk and decision making.

Robert F. Spiera, MD: Mycophenolate Treatment Is Associated with Improved Outcomes in Trial of Lenabasum in Patients With Systemic Sclerosis

November 22, 2021

Robert F Spiera, MD, explains background mycophenolate treatment and its associated improved outcomes in patients with systemic sclerosis receiving lenabasum.

Kelly Gavigan, MPH: Patient-Reported Outcome Scores During the COVID-19 Pandemic

November 18, 2021

Kelly Gavigan, MPH, discusses the changes in patient-reported outcome scores during the COVID-19 pandemic.